Home > Boards > US Listed > Miscellaneous > ZIOPHARM Oncology Inc (ZIOP)

Closed above 200 DMA on increased volume.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Plegee Member Profile
 
Followed By 2
Posts 113
Boards Moderated 0
Alias Born 08/17/06
160x600 placeholder
 ISS Recommends Ziopharm Shareholders Vote for Change on WaterMill Asset Management’s WHITE Consent Card Business Wire - 11/25/2020 8:30:00 PM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 11/24/2020 4:46:01 PM
WaterMill Asset Management Sets the Record Straight Following Ziopharm’s Apparent Attempt to Mislead Shareholders & Rewrite... Business Wire - 11/24/2020 9:00:00 AM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 11/23/2020 5:24:16 PM
Ziopharm Releases Investor Presentation Highlighting Execution of Strategy and Substantial Board Refreshment to Enhance Share... GlobeNewswire Inc. - 11/20/2020 11:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/20/2020 6:01:35 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/19/2020 4:49:13 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/19/2020 4:47:21 PM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 11/19/2020 4:14:47 PM
WaterMill Asset Management Releases Presentation Detailing the Case for Urgent Change Atop Ziopharm Oncology Business Wire - 11/19/2020 9:30:00 AM
White Rock Capital Supports WaterMill's Case for Change at Ziopharm Oncology PR Newswire (US) - 11/19/2020 9:00:00 AM
Ziopharm Oncology Presents Encouraging Clinical Data for Controlled IL-12 for the Treatment of Glioblastoma and DIPG at the 2... GlobeNewswire Inc. - 11/19/2020 9:00:00 AM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 11/18/2020 5:17:22 PM
Ziopharm Oncology Appoints Raffaele Baffa, M.D., Ph.D., as Chief Medical Officer GlobeNewswire Inc. - 11/17/2020 4:15:00 PM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 11/16/2020 2:49:22 PM
Ziopharm Oncology Appoints Mary Thistle to Board of Directors GlobeNewswire Inc. - 11/16/2020 8:30:00 AM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 11/13/2020 4:57:06 PM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 11/12/2020 3:08:10 PM
WaterMill Asset Management Releases Candid Q&As with Each of its Director Candidates for Election to Ziopharm Oncology’s Bo... Business Wire - 11/12/2020 9:00:00 AM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 11/5/2020 5:17:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2020 4:09:46 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/5/2020 4:04:00 PM
WaterMill Asset Management Sends Letter to Ziopharm Oncology Shareholders Business Wire - 11/5/2020 9:05:00 AM
Proxy Statement - Non-management (definitive, Revised) (dfrn14a) Edgar (US Regulatory) - 11/4/2020 4:10:11 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/2/2020 5:18:48 PM
Plegee   Saturday, 02/23/19 08:30:13 AM
Re: None
Post # of 1139 
Closed above 200 DMA on increased volume. Historically, not a strong indicator, but who knows if this time it will be different.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences